A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.
A post-marketing, open-label study to assess the tolerability and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.